OPK Q4 2020 Earnings — OPKO Health, Inc. Revenue & Financial Results | Market Cap Arena

OPKOPKO Health, Inc.

$933M

Q4 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$495M+120.5% YoY

Gross Profit

$176M35.6% margin

Operating Income

$49M10.0% margin

Net Income

$32M6.5% margin

EPS (Diluted)

$0.05

QoQ Revenue Growth

+15.5%

Cash Flow

Operating Cash Flow

$34M

Free Cash Flow

$27M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$2.5B

Total Liabilities

$802M

Stockholders' Equity

$1.7B

Cash & Equivalents

$72M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$495M	$224M	+120.5%
Gross Profit	$176M	$82M	+114.4%
Operating Income	$49M	-$112M	+143.8%
Net Income	$32M	-$112M	+128.7%

Revenue Segments

Service

$458M47%

Client Payers

$250M26%

Health Insurers

$164M17%

Product

$31M3%

Government Payers

$26M3%

Rayaldee

$21M2%

Patients

$19M2%

Transfer Of Intellectual Property And Other

$6M1%

Geographic Segments

UNITED STATES

$470M95%

CHILE

$11M2%

IRELAND

$6M1%

SPAIN

$5M1%

MEXICO

$2M0%

ISRAEL

$241,0000%

Other Countries

$128,0000%